1. Home
  2. Research
  3. Research Groups
  4. Neurodegenerative diseases: pathogenic mechanisms

Neurodegenerative diseases: pathogenic mechanisms

2023 Activity indicators

  • 6 public competitive projects led: ISCIII, MICINN, CIBERNED
  • 1 private competitive project led
  • 4 competitive HR contract
  • 7 publications.
  • IF: 76.20
  • Publications in D1: 6 (86%)
  • Publications in Q1: 3 (43%)
  • Project evaluators: 1 PI
  • Members of editorial committees: 1 PI
  • 1 visitor hosted and 5 months stay:  
    • National Autonomous University of Mexico (UNAM)
  • 11 months stay in foreign centres: 
    • EMBL-European Molecular Biology Laboratory
  • 1 European patent maintained. Number EP2733205, on methods of neural stem cell differentiation by modulation of CB1. 

Milestones

  1. Maroto IB, Costas-Insua C, Berthoux C, Moreno E, Ruiz-Calvo A, Montero-Fernández C, Macías-Camero A, Martín R, García-Font N, Sánchez-Prieto J, Marsicano G, Bellocchio L, Canela EI, Casadó V, Galve-Roperh I, Núñez Á, Fernández de Sevilla D, Rodríguez-Crespo I, Castillo PE, Guzmán M. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43. Nat Commun. 2023; 14(1):2303. DOI: 10.1038/s41467-023-38026-2. PMID: 37085487
  2. Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Adámez S, Andradas C, Manzano S, Álvarez-López I, Sarasqueta C, Villa-Morales M, González-Lois C, Ramírez-Medina E, Almoguera B, Sánchez-López AJ, Bindila L, Hamann S, Arnold N, Röcken C, Heras-Murillo I, Sancho D, Moreno-Bueno G, Caffarel MM, Guzmán M, Sánchez C, Pérez-Gómez E. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer. Nat Commun. 2023; 14(1):3130. DOI: 10.1038/s41467-023-38750-9. PMID: 37253733
  3. Guzmán, M. (2023) Fatty acids fueling astroglia and beyond. Nat. Metab. 5, 1253-1254.
  4. Maroto IB, Moreno E, Costas-Insua C, Merino-Gracia J, Diez-Alarcia R, Álvaro-Blázquez A, Canales Á, Canela EI, Casadó V, Urigüen L, Rodríguez-Crespo I, Guzmán M. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43. Neuropharmacology. 2023; 240:109712. DOI: 10.1016/j.neuropharm.2023.109712. PMID: 37689260.
  5. Costas-Insua C, Guzmán M. Endocannabinoid signaling in glioma. Glia. 2023; 71(1):127-138. doi: 10.1002/glia.24173. PMID: 35322459.

Bibliometrics

  Articles Accum. IF Mean IF Articles QI or Q2 % in Q1 or Q2 Articles D1 % in D1
2019 5 28.08 5.62 5 100 1 20
2020 10 128.66 12.87 10 100 7 70
2021 6 36.42 6.07 5 83 2 33
2022 2 13.23 6.61 2 100 1 50
2023 7 76.20 10.89 7 100 3 43
  30 282.59 8.41 29 97 14 47

* Only original articles, editorials, guidelines & reviews

Networks and alliances